Several GLP-1RAs have been approved for the treatment of obesity
Clinics that provide clear pricing information, accept insurance, and offer flexible visit options score higher because these factors directly affect your ability to access and afford treatment
Clinical trial data have produced mixed findings that require careful interpretation
GLP-1 RAs have also been associated with pancreatitis, which has predominantly been linked to gallbladder disease as a secondary effect of weight loss [88]
In addition, errors exist in most genome assemblies, thus, the identification of a sequence that contains a unique mutation or amino acid substitution must be treated with caution
The same CDC report reveals that nearly 8% of Americans were severely obese in 2015-2016, up from 5.7% in 2007-2008